Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion type Assertion NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_head.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion evidence source_evidence_literature NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion SIO_000772 22660274 NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion wasDerivedFrom befree-20140225 NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion wasGeneratedBy ECO_0000203 NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.